1 year return (CAGR)
380.66%
Iovance Biotherapeutics Inc Exchange (NASDAQ, USD)
IOVA
10.19
-0.45 (-4.23%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
19.78%
5 year return (CAGR)
-15.77%
10 year return (CAGR)
2.57%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
4.62B
Price/Sales
14.20
Ent value
4.68B
Price/Book
6.27
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-10.23%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 10.66 |
| Daily high | 10.85 |
| Daily low | 10.12 |
| Daily Volume | 15.9M |
| All-time high | 159.00 |
| 1y analyst estimate | 10.00 |
| Beta | 0.83 |
| EPS (TTM) | -0.64 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| IOVA | S&P500 | |
| Current price drop from All-time high | -93.59% | -1.29% |
| Highest price drop | -99.36% | -56.47% |
| Date of highest drop | 7 May 2013 | 9 Mar 2009 |
| Avg drop from high | -86.03% | -10.68% |
| Avg time to new high | 136 days | 12 days |
| Max time to new high | 3706 days | 1805 days |
News
